Global Indemnity Group (GBLI)
NYSE: GBLI
· Real-Time Price · USD
30.95
-0.13 (-0.42%)
At close: May 20, 2025, 3:57 PM
30.95
0.00%
After-hours: May 20, 2025, 04:05 PM EDT
Global Indemnity Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Commercial Specialty Segment Revenue | 377.95M | 340.03M | 285.69M | 237.76M | 51.4M | 86.72M | 82.91M | 114.64M | 104.84M | 118.69M |
| Commercial Specialty Segment Revenue Growth | +11.15% | +19.02% | +20.16% | +362.55% | -40.73% | +4.60% | -27.68% | +9.35% | -11.67% | n/a |
| Exited Lines Segment Revenue | 83.23M | 105.88M | 74.56M | 75.96M | n/a | n/a | n/a | n/a | n/a | n/a |
| Exited Lines Segment Revenue Growth | -21.39% | +42.01% | -1.85% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Reinsurance Operations Revenue | 141.29M | 77.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Reinsurance Operations Revenue Growth | +81.60% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | 6.37M | 6.37M | 6.87M | 5.28M | 4.99M | 6.37M | 11.86M | 4.91M | 2.99M | 4.66M | 11.19M | 5.39M | 6.33M | 4.28M | 7.96M | 21.2M | 8.62M | 4.22M | 7.19M | 3.86M | 4.64M | 3.21M | 6.11M | 3.48M | 10.92M | 9.26M | 14.67M | 4.63M | 3.36M | 3.05M | 4.27M | 5.01M | 4.25M | 3.8M | 5.01M | 3.57M | 4.33M | 11.54M |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | -100.00% | -0.11% | -7.22% | +30.09% | +5.81% | -21.64% | -46.29% | +141.42% | +64.08% | -35.77% | -58.34% | +107.67% | -14.88% | +48.01% | -46.29% | -62.44% | +145.95% | +104.07% | -41.23% | +86.26% | -16.84% | +44.74% | -47.57% | +75.91% | -68.17% | +17.90% | -36.87% | +216.83% | +37.76% | +10.05% | -28.54% | -14.62% | +17.65% | +11.89% | -24.05% | +40.37% | -17.70% | -62.44% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |